A mutant EGF-receptor defective in ubiquitylation and endocytosis unveils a role for Grb2 in negative signaling

AUTOR(ES)

Waterman, Hadassa

FONTE

Oxford University Press

RESUMO

Ligand-induced desensitization of the epidermal growth factor receptor (EGFR) is controlled by c-Cbl, a ubiquitin ligase that binds multiple signaling proteins, including the Grb2 adaptor. Consistent with a negative role for c-Cbl, here we report that defective Tyr1045 of EGFR, an inducible c-Cbl docking site, enhances the mitogenic response to EGF. Signaling potentiation is due to accelerated recycling of the mutant receptor and a concomitant defect in ligand-induced ubiquitylation and endocytosis of EGFR. Kinetic as well as morphological analyses of the internalization-defective mutant receptor imply that c-Cbl-mediated ubiquitylation sorts EGFR to endocytosis and to subsequent degradation in lysosomes. Unexpectedly, however, the mutant receptor displayed significant residual ligand-induced ubiquitylation, especially in the presence of an overexpressed c-Cbl. The underlying mechanism seems to involve recruitment of a Grb2 c-Cbl complex to Grb2-specific docking sites of EGFR, and concurrent acceleration of receptor ubiquitylation and desensitization. Thus, in addition to its well-characterized role in mediating positive signals, Grb2 can terminate signal transduction by accelerating c-Cbl-dependent sorting of active tyrosine kinases to destruction.

Documentos Relacionados

• Biological activities of EGF-receptor mutants with individually altered autophosphorylation sites.
• RFLP for an EGF-receptor related gene associated with the melanoma oncogene locus of Xiphophorus maculatus.
• A point mutation at the ATP-binding site of the EGF-receptor abolishes signal transduction.
• Functional analysis of the ligand binding site of EGF-receptor utilizing chimeric chicken/human receptor molecules.
• Domain deletion in the extracellular portion of the EGF-receptor reduces ligand binding and impairs cell surface expression.